Daniel R. Chevallard
Chief Financial Officer at LENZ Therapeutics · 2 reported transactions in 1 company · latest trade Nov 7, 2025
Their record
Across their whole record, 1 purchase can be measured; 0 did better than the S&P 500 over the next 6 months.
Typical move −59.6%, S&P 500 +7.0% over the same days.
Their trades
Bought | Nov 7, 2025 | Nov 7, 2025 close $22.97 → Oct 30, 2026 close $3.05. S&P 500 +12.6% over the same days. | ||
Bought | Nov 7, 2025 | Nov 7, 2025 close $22.97 → Oct 30, 2026 close $3.05. S&P 500 +12.6% over the same days. |
BoughtLENZ Therapeutics
$49.6K
Nov 7, 2025 close $22.97 → Oct 30, 2026 close $3.05. S&P 500 +12.6% over the same days.
BoughtLENZ Therapeutics
$454.20
Nov 7, 2025 close $22.97 → Oct 30, 2026 close $3.05. S&P 500 +12.6% over the same days.